We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Marten Transport
MRTN
$1.22B
| $2.15M | ﹤0.01% |
199,004
+25,019
| +14% | +$313K |
|
|
ARCH
1602
DELISTED
Arch Resources, Inc.
ARCH
| $2.15M | ﹤0.01% |
25,849
+6,695
| +35% | +$595K |
|
1603
Kelly Services Class A
KELYA
$528M
| $2.14M | ﹤0.01% |
104,621
+16,126
| +18% | +$359K |
|
1604
First Interstate BancSystem
FIBK
$3.63B
| $2.14M | ﹤0.01% |
58,547
+13,998
| +31% | +$582K |
|
1605
Fossil Group
FOSL
$349M
| $2.14M | ﹤0.01% |
135,780
+22,740
| +20% | +$440K |
|
1606
Alamo Group
ALG
$2.04B
| $2.13M | ﹤0.01% |
27,598
+4,788
| +21% | +$399K |
|
1607
OFG Bancorp
OFG
$2.25B
| $2.13M | ﹤0.01% |
129,394
+21,754
| +20% | +$366K |
|
|
PEGI
1608
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $2.13M | ﹤0.01% |
114,256
+34,148
| +43% | +$664K |
|
|
VIVO
1609
DELISTED
Meridian Bioscience Inc
VIVO
| $2.12M | ﹤0.01% |
122,287
+21,289
| +21% | +$363K |
|
|
NGHC
1610
DELISTED
National General Holdings Corp
NGHC
| $2.12M | ﹤0.01% |
87,343
+29,144
| +50% | +$742K |
|
1611
Buckle
BKE
$2.34B
| $2.11M | ﹤0.01% |
109,077
+13,707
| +14% | +$278K |
|
1612
MGP Ingredients
MGPI
$379M
| $2.1M | ﹤0.01% |
36,879
+6,416
| +21% | +$433K |
|
1613
Installed Building Products
IBP
$6.51B
| $2.1M | ﹤0.01% |
62,219
+10,639
| +21% | +$370K |
|
1614
Laureate Education
LAUR
$5.24B
| $2.1M | ﹤0.01% |
137,522
+54,746
| +66% | +$820K |
|
1615
Sturm, Ruger & Co
RGR
$614M
| $2.1M | ﹤0.01% |
39,379
+7,766
| +25% | +$448K |
|
|
MB
1616
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $2.1M | ﹤0.01% |
57,582
+19,177
| +50% | +$584K |
|
|
AKS
1617
DELISTED
AK Steel Holding Corp
AKS
| $2.1M | ﹤0.01% |
931,080
+135,297
| +17% | +$489K |
|
|
CHS
1618
DELISTED
Chicos FAS, Inc.
CHS
| $2.09M | ﹤0.01% |
372,360
+61,159
| +20% | +$426K |
|
1619
SiriusPoint
SPNT
$2.74B
| $2.08M | ﹤0.01% |
215,608
+31,214
| +17% | +$335K |
|
|
ZGNX
1620
DELISTED
Zogenix, Inc.
ZGNX
| $2.07M | ﹤0.01% |
56,857
+17,753
| +45% | +$727K |
|
1621
PTC Therapeutics
PTCT
$5.78B
| $2.07M | ﹤0.01% |
60,379
+19,444
| +47% | +$699K |
|
|
WCC
1622
WESCO International
WCC
$18.2B
| $2.07M | ﹤0.01% |
43,164
+1,432
| +3% | +$74.3K |
|
1623
Kulicke & Soffa
KLIC
$4.91B
| $2.07M | ﹤0.01% |
102,055
+5,023
| +5% | +$104K |
|
1624
Amphastar Pharmaceuticals
AMPH
$877M
| $2.07M | ﹤0.01% |
103,943
+16,080
| +18% | +$317K |
|
|
AHRT
1625
AH Realty Trust
AHRT
$518M
| $2.06M | ﹤0.01% |
146,652
+29,159
| +25% | +$435K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.